Michelle Ho, Ph.D., joined the Laboratory of Translational Genomics (LTG) in 2020 as a postdoctoral fellow in the laboratory of Ludmila Prokunina-Olsson, Ph.D., LTG Director and senior investigator. Dr. Ho earned her Ph.D. in biological sciences in 2020 from the City of Hope Irell & Manella Graduate School in Duarte, California. Her previous research focused on the development of gene editing tools for various inherited disorders. Working with Drs. John Burnett and John Rossi, her doctoral research focused on developing methods to import CRISPR/Cas systems into mitochondria and optimizing CRISPR designs to target mutations in mitochondrial DNA.
Dr. Ho's research focuses on using CRISPR-based methods to screen genetic risk variants and functionally characterize their relationships to bladder cancer development, under the mentorship of Dr. Prokunina-Olsson.